presseportal.de : Amgen to Present Pivotal Data From Four Phase 3 S...
Geschrieben von rootam 17.09.2009 00:25:16 (28 x gelesen)
Amgen Inc.: Thousand Oaks, California (ots/PRNewswire) - - Key Denosumab and Vectibix(R) (Panitumumab) Data to be Presented Amgen (Nasdaq: AMGN) today announced it will present detailed data from four Phase 3 studies as well as other data ...
